Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

4.900 -0.060 (-1.21%)
Streaming Delayed Price Updated: 11:53 AM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,806
Open 5.070
Bid (Size) 4.870 (100)
Ask (Size) 4.990 (200)
Prev. Close 4.960
Today's Range 4.855 - 5.135
52wk Range 4.830 - 8.740
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Champions Oncology Q4 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported record revenue for fiscal 2026 and positive adjusted EBITDA in every quarter of the year, supported by growth in its core Translational Oncology Solutions, or... 
Via MarketBeat
Topics Earnings
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
Via Chartmill
Topics Earnings

Performance

YTD
-26.4%
-26.4%
1 Month
-20.1%
-20.1%
3 Month
-18.1%
-18.1%
6 Month
-16.2%
-16.2%
1 Year
-30.6%
-30.6%

More News

Read More
News headline image
Champions Oncology Reports Record Annual Revenue of $59 Million
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Via ACCESS Newswire
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
Via Chartmill
News headline image
Insights Ahead: Champions Oncology's Quarterly Earnings ↗
Via Benzinga
News headline image
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Via ACCESS Newswire
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Via The Motley Fool
News headline image
Champions Oncology Reports Revenue of $16.6 Million
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Via ACCESS Newswire
News headline image
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Champions Oncology (CSBR) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Via The Motley Fool
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
Via ACCESS Newswire
News headline image
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Earnings Scheduled For September 15, 2025 ↗
Via Benzinga
News headline image
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Via ACCESS Newswire
News headline image
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
Via Benzinga

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 4.900
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 08/24/26 11:53 AM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 65.73M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.